期刊文献+

p53基因和端粒酶活性在良、恶性梗阻性黄疸中的表达 被引量:2

Expression of telomerase and p53 gene in benign and malignant obstructive jaundice
下载PDF
导出
摘要 目的探讨p53基因和端粒酶活性在良、恶性梗阻性黄疸中的表达。方法选取恶性梗阻性黄疸患者64例作为实验组,良性梗阻性黄疸患者60例作为对照组,采用端粒重复序列扩增-聚合酶链式反应-酶联免疫吸附测定法检测端粒酶活性,流式细胞仪检测p53蛋白的阳性表达率。结果恶性和良性梗阻性黄疸组织标本中端粒酶表达阳性率分别为87.50%和3.33%,p53蛋白阳性表达率分别为71.88%和0。结论端粒酶活性和p53蛋白阳性表达与淋巴转移率和肿瘤的分化程度有明显关系。端粒酶和p53基因可以作为胆、胰系统恶性肿瘤诊断的有力标志物,联合检测可以提高恶性梗阻性黄疸的确诊率。 Objective To investigate the expression of telomerase and p53 gene in biliary-pancreatic system cancer. Methods 64 patients with malignant biliary Obstruction were selected as experimental group and 60 patients with benign biliary obstruction as control group. The telomerase activity was tested with telomere repeat amplification protocol-polymerase chain reaction-enzyme linked immunosorbent assay and the expression of p53 was tested by flow cytometry. Results The telomerase activity and p53 positive rate of patients with malignant obstructive jaundice were 87.5% and 71.88%. Correspondingly, they were 3.33% and 0 in benign biliary obstruction. Conclusion Testing the expressions of telomerase and p53 can improve the accuracy and sensitivity in diagnoses of malignant biliary obstruction.
出处 《兰州大学学报(医学版)》 CAS 2010年第1期13-16,共4页 Journal of Lanzhou University(Medical Sciences)
基金 甘肃省自然科学基金(ZS001-A23-075-Y)
关键词 P53基因 端粒酶 梗阻性黄疸 p53 gene telomerase obstructive jaundice
  • 相关文献

参考文献11

  • 1李兆申.胰腺癌早期诊断研究的现状与展望[J].解放军医学杂志,2009,34(1):7-9. 被引量:17
  • 2急性胰腺炎协作组.中国6223例急性胰腺炎病因及病死率分析[J].胰腺病学,2006,6(6):321-325. 被引量:166
  • 3黄洁夫主编..腹部外科学[M].北京:人民卫生出版社,2001:1721.
  • 4KAKIHANA M, YAHATA N, HIRANO T, et al. Telomerase activity during carcinogenesis in the bronchus[J]. Oncol Rep, 2002, 9(1): 43-49. 被引量:1
  • 5OLAUSSAN K A, DUBRANA K, DOMONT J, et al. Telomeres and telomerase as targets for anti- cancer drug development[J]. Crit Rev Oncol Hematol, 2006, 57(3): 191-195. 被引量:1
  • 6HAUGUEL T, BUNZ F. Haploinsuffciency of hTERT leads to telomere dysfunction and radiosensitivity in human cancer cells[J]. Cancer Boil Ther, 2003, 2(6): 679-683. 被引量:1
  • 7LIu Su-xing, BISHOP W R, DASMAHAPATRA B, et al. Pharmacogenomics of the p53 tumor suppressor and its rolein cancer chemoresistance[J]. Drug Development Research, 2004, 62(3): 254-272. 被引量:1
  • 8COLLOT,TEIXEIRA S, BASS J, DENIS F, etal. Human tumor suppressor p53 and DNA viruses[J]. Reviews in Medical Virology, 2004, 14(5): 301-319. 被引量:1
  • 9PANTALONE D, PELO E, MINUTI B, et al. p53 and DPC4 alterations in the bile of patients with pancreatic carcinoma[J]. Journal of Surgical Oncology, 2004, 88(4): 210-216. 被引量:1
  • 10SUTO T, HABANO W, SUGAI T, et al. Infrequent microsatellite instability in biliary tract cancer[J]. Journal of Surgical Oncology, 2001, 76(2): 121-126. 被引量:1

二级参考文献48

共引文献181

同被引文献18

  • 1钱晓军,戴定可,翟仁友.恶性梗阻性黄疸介入治疗的疗效分析[J].中华肝胆外科杂志,2004,10(11):752-755. 被引量:93
  • 2田虎.ERCP和EST诊治胆胰系疾病研究进展[J].山东医药,2005,45(9):72-73. 被引量:18
  • 3倪泉兴,杨峰.规范诊治,努力提高胰腺癌的远期生存率[J].中国普外基础与临床杂志,2006,13(5):493-495. 被引量:8
  • 4向华,刘觉仕,张智明,潘能玉,方志勇,马宝林.胆道支架经皮置入术治疗恶性梗阻性黄疸[J].医学临床研究,2007,24(5):810-812. 被引量:6
  • 5SCHODER M, ROSSI P, UFLACKER R, et al. Malig- nant biliary obstruction: treatment with eptfe-FEP- covered endoprostheses initial technical and cli.ni- cal experiences in a multicenter trial[J]. Radiology, 2002, 225(1): 35-42. 被引量:1
  • 6HAN Young-min, JIN Gong-yong, LEE S O, et al. Flared polyurethane-covered self-expandable nitinol stent for malignant biliary obstruction[J]. J Vasc In-terv Radiol, 2003, 14(10): 1 291-1301. 被引量:1
  • 7INAL M, AKQiJL E, AKSUNQUR E, et al. Percuta- neous placement of biliary metallic stents in pa-tients with malignant hilar obstruction: unilobar versus bilobar drainage[J]. J Vasc Interv Radiol, 2003, 14(11): 1409-1416. 被引量:1
  • 8HAMMARSTROM L E. Endobiliary stents for palli- ation in patients with malignant obstructive jaun-dice[J]. J Clin Gastroenterol, 2005, 39(5): 413-421. 被引量:1
  • 9[NDAR A A, LOBO D N, GILLIAM A D, et al. Per-cutaneous biliary metal obstructive jaundice[J] wall stenting in malignant Eur J Gastroenterol Hepa- tol, 2003, 15(8): 915-919. 被引量:1
  • 10LEE J W, HAN J K, KIM T K, et al. Obstructive jaundice in hepatocellular carcinoma: response af- ter percutaneous transhepatic biliary drainage and prognostic factors[J]. Cardiovasc Intervent Radiol, 2002, 25(3): 176-179. 被引量:1

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部